Innovative drug sector continues to surge, Zhongyuan Xiehe hits the daily limit

The innovative drug sector keeps pushing higher. Zhongyuan Concord reached the daily limit. Aiyong Biopharmaceuticals rose more than 15%. BeiBet, Beilu Pharmaceutical, Shanghai Yizhong, Wanze Shares, and Rejing Bio also moved in tandem.

Regarding related ETFs: the Innovative Drugs ETF (515120) rose 2.06%, with trading volume of 105 million yuan. The Innovative Drugs ETF Morgan (560900) rose 2.27%, with trading volume of 2.4511 million yuan.

In terms of news, the Government Work Report includes biopharmaceuticals as a new emerging pillar industry, alongside integrated circuits, aerospace, low-altitude economy, and other industries.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments